Mar 20, 2020  |  Faculty

Professor Ollis Has Retired

Dr. David F. Ollis, University Distinguished Professor of Chemical and Biomolecular Engineering, retired from his faculty position, effective with the 2020 spring semester. Professor Ollis earned his B.S., M.S. and Ph.D. degrees, all in chemical engineering, from Caltech, Northwestern and […]

Mar 10, 2020  |  Research

The 2020 Schoenborn Symposium was an Outstanding Success!

The Schoenborn Symposium is a showcase for the talent and accomplishments of our graduate students. The Symposium has two sections. During the first section, senior-level Ph.D. candidates make formal presentations about their research and the associated results. During the second […]

Mar 3, 2020  |  Awards and Honors

Professor Dickey Selected for Alumni Association Outstanding Research Award

Dr. Michael Dickey, Alcoa Professor of Chemical and Biomolecular Engineering, has been selected to receive a 2020 Alumni Association Outstanding Research Award. The honor includes being inducted into the NC State Research Leadership Academy (RLA). First presented in 1981, the […]

Feb 27, 2020  |  Awards and Honors

Professor Santiso Selected as a University Faculty Scholar

Professor Erik Santiso has been selected as a member of the 2019-20 class of University Faculty Scholars. The University Faculty Scholars Program was established in 2012 by Chancellor Randy Woodson “to recognize and reward emerging academic leaders among our faculty…” […]

Feb 18, 2020  |  Research

Studying Switchable Solvents

This article is a modified version of an article written by Matt Shipman, Research Lead in University Communications. Most chemical manufacturing operations utilize significant amounts of liquid solvents. Examples are solvents that carry dissolved or suspended constituents while flowing in […]

Jan 24, 2020  |  Research

Professors Menegatti and Carbonell Receive Chancellor’s Innovation Fund Support

Professors Stefano Menegatti and Ruben Carbonell have received $60,000 from the Chancellor’s Innovation Fund (CIF) to develop and commercialize a novel technology for the purification of therapeutic monoclonal antibodies (mAbs). Established by Chancellor Woodson in 2010, the CIF mission is […]